2020 Revenues ($USD) : $11,701,891,740
2020 Revenues (foreign currencies) : JP¥1249528000000
2020 R&D spend : $2,102,350,627.46
2020 Number of Employees : 15,455
Fiscal Year End : 3/31/2021
Key People : Kenji Yasukawa, CEO; Naoki Okamura, corporate EVP, chief strategy officer and CFO; Fumiaki Sakurai, CAO and chief ethics & compliance officer; Dr. Bernhardt Zeiher, chief medical officer; Yukio Matsui, CCO; Yoshitsugu Shitaka, chief scientific officer; Percival Barretto-Ko, chief business officer; Catherine Levitt, general counsel

Astellas Pharma is a Tokyo-based company developing pharmaceuticals for a broad range of therapeutics, including cardiology, immunology, infectious disease, oncology and urology. The company commercializes 12 drugs in the U.S., with its Xtandi prostate-cancer-treating drug leading sales in its most recent fiscal year. –DK